Clinical Study
Resistance Training and Testosterone Levels in Male Patients with Chronic Kidney Disease Undergoing Dialysis
Table 2
Hormone levels for the patients (
) and for the age-matched male reference population.
| | Variables | All patients () | Reference population | P |
| | Total T (nmol/L) | 19.5 (8.2–52.1) | 17.6 (16.1–18.0) | 0.174 | | Free T (pmol/L) | 473 (174–1057) | 289 (226–377) | 0.004 | | IGF-1 (ng/mL) | 203 (59–590) | 151 (128–276) | 0.014 | | IGF-BP3 (ng/mL) | 5045 (3370–9370) | 3244 (3020–3983) | <0.001 | | IGF-1/IGF-BP3 | 0.0443 (0.0158–0.0630) | 0.04652 (0.0400–0.0694) | 0.102 | | SHBG (nmol/L) | 42.0 (8.0–132.0) | 48.0 (32.9–59.4) | 0.211 | | LH (U/L) | 13.0 (5.5–82.8) | 4.3 (3.3–4.6) | <0.001 | | FSH (U/L) | 9.7 (1.7–86.1) | 7.0 (3.3–7.5) | 0.091 | | Total T/LH | 2.1 (0.2–5.0) | 4.1 (3.6–5.5) | <0.001 | | Estradiol (pmol/L) | 105 (75–133) | 117 (94–123) | 0.096 | | Inhibin-B (pg/mL) | 170 (1–403) | 142 (134–165) | 0.659 | | Inhibin-B/FSH | 18.7 (0.1–235.7) | 20.3 (17.9–49.0) | 0.445 |
|
|
Data are presented as median (range). T: testosterone; SHBG: sex hormone-binding globulin.
|
